Transdermal delivery of antiparkinson agents
US6929801B2 · kind B2 · utility
154Cited by
15References
18Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | May 2, 2003 |
| Grant date | Aug 16, 2005 |
| Priority date | — |
| Expiry date | Jul 3, 2023 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61Q17/04
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention provides a transdermal drug delivery system which comprises: a therapeutically effective amount of an antiParkinson agent; at least one dermal penetration enhancer, which is a safe skin-tolerant ester sunscreen ester; and at least one volatile liquid. The invention also provides a method for administering at least one systemic acting antiParkinson agent to an animal which comprises applying an effective amount of the antiParkinson agent in the form of the drug delivery system of the present invention.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.